3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
27
Prostatic Neoplasms
26
Brain Neoplasms
23
Lung Neoplasms
17
Neoplasm Metastasis
15
Breast Neoplasms
12
Melanoma
9
Carcinoma, Renal Cell
8
Pancreatic Neoplasms
6
Colorectal Neoplasms
6
Carcinoma, Hepatocellular
4
Urinary Bladder Neoplasms
3
Neoplasms
3
NSCLC
3
Meningioma
3
Gastrointestinal Neoplasms
3
Unresectable Locally Recurrent Rectal Cancer
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Spinal Cord Compression
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Epidural Neoplasms
2
Carcinoma, Transitional Cell
2
Adenocarcinoma
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Interventions
X-Rays
7
Phantoms, Imaging
7
Magnetic Resonance Spectroscopy
7
Specimen Handling
6
Nuclear Medicine Department, Hospital
5
Biopsy
4
tazemetostat
3
Cyclophosphamide
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Vincristine
2
Topotecan
2
Methotrexate
2
LY3023414
2
Etoposide
2
Cisplatin
2
Carboplatin
2
talazoparib
1
selinexor
1
pembrolizumab
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
Radiosurgery
×
90 days
×
Clear all
No trials found.